Postoperative Chryseobacterium indologenes bloodstream infection caused by contamination of distillate water

Infection Control and Hospital Epidemiology

Volumn 28, Issue 3, 2007, Pages 368-369

  Bayraktar, Mehmet Refik ^a,c   Aktas, Elif ^a,b   Ersoy, Yasemin ^a   Cicek, Aysegul ^a   Durmaz, Riza ^a  

^a INONU UNIVERSITY   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; OFLOXACIN; VANCOMYCIN;

ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BLOOD SAMPLING; CASE REPORT; CHRYSEOBACTERIUM INDOLOGENES; CLINICAL FEATURE; DOWN SYNDROME; HEART ATRIUM SEPTUM DEFECT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; MALE; MORTALITY; MYCOSIS; POLYMERASE CHAIN REACTION; SEPSIS; WATER CONTAMINATION;

BACTEREMIA; BLOOD; CHRYSEOBACTERIUM; CULTURE MEDIA; FATAL OUTCOME; FLAVOBACTERIACEAE INFECTIONS; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; PEDIATRICS; TURKEY; WATER POLLUTION; WATER SUPPLY;

EID: 33947602164     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/508839     Document Type: Article

References (10)

1. Hsueh PR, Hsiue TR, Wu JJ, et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996; 23: Z550-555.
2. Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997; 41:2738-2741.
3. Hsueh PR, Chang JC, Teng LJ, et al. Comparison of E test and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates. J Clin Microbiol 1997; 35:1021-1023.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility tests. Approved standard M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
5. Welsh I, McClelland M. Characterization of pathogenic microorganisms by genomic fingerprinting used arbitrarily primed PCR. In: Persing DH, Smith TF, Tenover F, et al., eds. Diagnostic Molecular Microbiology: Principles and Applications. Washington, DC: American Society for Microbiology, 1993:595-602.
6. Grundmann HJ, Towner KJ, Dijkshoorn L, et al. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 1997; 35:3071-3077.
7. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001; 7: 391-393.
8. Squier C, Yu VL, Stout JE. Waterborne nosocomial infections. Curr Infect Dis Rep 2000; 2:490-496.
9. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004; 42:445-448.
10. Merino LA, Ronconi MC, Marin M, Hrenuk GE, Pato AM. Non-fermenting gram-negative bacilli: distribution in clinical specimens and antimicrobial susceptibility. Rev Latinoam Microbiol 1999; 41:279-284.